+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Australia
From
India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • India
From
Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Italy
From
Germany Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Germany Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Germany
From
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 35 Pages
  • Global
From
Glioblastoma Multiforme Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Glioblastoma Multiforme Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 33 Pages
  • Global
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 1353 Pages
  • Global
From
Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • July 2022
  • 56 Pages
  • Global
From
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 548 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 1381 Pages
  • Global
From
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape - Product Thumbnail Image

Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape

  • Report
  • May 2022
  • 75 Pages
  • Global
From
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 - Product Thumbnail Image

Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

  • Drug Pipelines
  • February 2022
  • 150 Pages
  • Global
From
T-Cell Lymphomas - Epidemiology Forecast to 2030 - Product Thumbnail Image

T-Cell Lymphomas - Epidemiology Forecast to 2030

  • Report
  • January 2022
  • 44 Pages
  • Global
From
Brain Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 42 Pages
  • Global
From
Chronic Myeloid Leukemia (CML) - Epidemiology Forecast to 2030 - Product Thumbnail Image

Chronic Myeloid Leukemia (CML) - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 37 Pages
  • Global
From
Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 141 Pages
  • Global
From
Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 127 Pages
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2030

  • Report
  • May 2021
  • 42 Pages
  • Global
From
Pancreatic Cancer - Epidemiology Forecast to 2029 - Product Thumbnail Image

Pancreatic Cancer - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 46 Pages
  • Global
From
Acute Lymphocytic Leukemia - Epidemiology Forecast to 2029 - Product Thumbnail Image

Acute Lymphocytic Leukemia - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 29 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more